Feature

Laboratory Manager: Thinzar Myint (BS, MS)…

University of Florida researchers will use a new $5 million grant to develop a “pancreatic islet on a chip” — a platform that will allow them to more efficiently and effectively study Type 1 diabetes and potential treatments for the condition.

Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) The early life events that influence immune system development have implications in the development of a multitude of diseases including type 1 diabetes (T1D). The immune system is actively evolving and integrating dynamic signals from the host’s environment, not…

University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T cell receptor sequences in Type 1 Diabetes. Congratulations to co-investigators Dr. Todd Brusko and Dr. Mark Peakman!…

The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”…

The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).

The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk…

Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.

From undergraduate students to post-doctoral fellows – every set of hands is important.

View how Dr. Brusko’s research has progressed and see where our research currently stands.